Axogen Inc (FRA:LT3)
€ 6.5 -0.05 (-0.76%) Market Cap: 276.97 Mil Enterprise Value: 324.91 Mil PE Ratio: 0 PB Ratio: 3.19 GF Score: 63/100

AxoGen Inc at Jefferies London Healthcare Conference Transcript

Nov 15, 2022 / 10:20AM GMT
Release Date Price: €11.8 (-4.84%)
Mike Sarcone
UBS Securities LLC - Analyst

My name is Mike Sarcone. I work on the US Medical Supplies and Devices team. And with us today, we're happy to have Axogen. And from the team, we've got Karen Zaderej, Chairperson, President, and CEO; and Pete Mariani, Executive Vice President and CFO.

Karen, Pete, thank you for joining us.

Karen Zaderej
Axogen, Inc. - Chairman, CEO & President

Thank you.

Pete Mariani
Axogen, Inc. - EVP & CFO

Thank you.

Questions & Answers

Mike Sarcone
UBS Securities LLC - Analyst

So I guess just to kick it off for those who are newer to the story, do you think you can give us a quick overview of Axogen's product offering and applications and the value proposition versus standard of care? And then just secondly to that, can you touch on the progress you've made over the past few years in terms of driving adoption?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot